See All Slides - tctmd.com

Slides

Presentation TCT 2015

TCT 77: Risk and Benefits of Triple Therapy in Patients Undergoing Percutaneous Coronary Stent Implantation Requiring Chronic Oral Anticoagulation A Meta-analysis of 12 Trials

Presenter: Lisa K. Jennings, Neal S. Kleiman, Lucia Barbieri

October 13, 2015

Presentation TCT 2015

TCT 12: Impact of Overlap on Long-term Clinical Outcomes in Patients Undergoing Everolimus-Eluting Bioresorbable Vascular Scaffolds Implantation in Routine Clinical Practice Insights From the European Multicenter GHOST-EU Registry

Presenter: Stephen G. Ellis, Lorenz Raber, Luis Ortega-Paz

October 13, 2015

Presentation TCT 2015

TCT 85: Safety and Performance of the EnligHTN Renal Denervation System in Patients With Severe Uncontrolled Hypertension Twelve-Month Results From the EnligHTN II Study

Presenter: Michael A. Weber, Stephen G. Worthley, Melvin D. Lobo

October 13, 2015

Presentation TCT 2015

TCT 101: Experience With Cerebral Protection During Transcatheter Aortic Valve Replacement The ALSTER Registry

Presenter: Michael J. Reardon, Torsten P. Vahl, Tobias Schmidt

October 13, 2015

Presentation TCT 2015

TCT 69: Impact of Stage 5 Chronic Kidney Disease in Patients Undergoing Percutaneous or Surgical Carotid Artery Revascularization Insights of the Healthcare Cost and Utilization Project's National Inpatient Sample

Presenter: Mark C. Bates, Mark H. Wholey, Fabio Lima

October 13, 2015

Presentation TCT 2015

TCT 92: Transcatheter Aortic Valve Replacement in Asian Pacific Countries

Presenter: Jeffrey J. Popma, Mathew Williams, Sung-Han Yoon

October 13, 2015

Presentation TCT 2015

TCT 100: Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease One-Year Outcomes From the CoreValve US Expanded Use Study

Presenter: Michael J. Reardon, Torsten P. Vahl, Daniel O'Hair

October 13, 2015

Presentation TCT 2015

TCT 27: Impact of Primary Stenting Compared to Balloon Dilatation Alone on Pulmonary Vein Restenosis

Presenter: John P. Cheatham, Carlos Pedra, R. Jay Widmer

October 13, 2015

Presentation TCT 2015

TCT 76: Six Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Biodegradable-Polymer Sirolimus-Eluting Stents for Bifurcation Lesions Insights From the I-LOVE-IT 2 Trial

Presenter: Lisa K. Jennings, Neal S. Kleiman, Bo Xu

October 13, 2015

Presentation TCT 2015

RIVER-PCI: A Prospective, Double-Blind, Placebo-Controlled Randomized Trial of Ranolazine in Patients With Incomplete Revascularization After Coronary Intervention

Presenter: Sunil V. Rao, Giora Weisz

October 13, 2015

Advertisement

Slides

TCT 77: Risk and Benefits of Triple Therapy in Patients Undergoing Percutaneous Coronary Stent Implantation Requiring Chronic Oral Anticoagulation A Meta-analysis of 12 Trials

TCT 12: Impact of Overlap on Long-term Clinical Outcomes in Patients Undergoing Everolimus-Eluting Bioresorbable Vascular Scaffolds Implantation in Routine Clinical Practice Insights From the European Multicenter GHOST-EU Registry

TCT 85: Safety and Performance of the EnligHTN Renal Denervation System in Patients With Severe Uncontrolled Hypertension Twelve-Month Results From the EnligHTN II Study

TCT 101: Experience With Cerebral Protection During Transcatheter Aortic Valve Replacement The ALSTER Registry

TCT 69: Impact of Stage 5 Chronic Kidney Disease in Patients Undergoing Percutaneous or Surgical Carotid Artery Revascularization Insights of the Healthcare Cost and Utilization Project's National Inpatient Sample

TCT 92: Transcatheter Aortic Valve Replacement in Asian Pacific Countries

TCT 100: Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease One-Year Outcomes From the CoreValve US Expanded Use Study

TCT 27: Impact of Primary Stenting Compared to Balloon Dilatation Alone on Pulmonary Vein Restenosis

TCT 76: Six Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Biodegradable-Polymer Sirolimus-Eluting Stents for Bifurcation Lesions Insights From the I-LOVE-IT 2 Trial

RIVER-PCI: A Prospective, Double-Blind, Placebo-Controlled Randomized Trial of Ranolazine in Patients With Incomplete Revascularization After Coronary Intervention

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content